SWLA healthcare providers limit monoclonal antibody infusions due to shortage

Published: Dec. 23, 2021 at 1:40 PM CST
Email This Link
Share on Pinterest
Share on LinkedIn

Lake Charles, LA (KPLC) - The monoclonal antibodies used in COVID-19 infusion treatments are in “severely limited supply” as COVID cases increase throughout Southwest Louisiana, according to local healthcare providers.

Lake Charles Memorial Health System, CHRISTUS Ochsner Health and West Calcasieu Cameron Hospital are limiting infusion treatments to those diagnosed with COVID who are 65 and older, have a BMI over 30, have cardiovascular disease, chronic kidney disease, chronic lung disease, diabetes, are pregnant or have an immunocompromised condition.

These previously offered monoclonal antibody infusion treatment seems to be less effective against the Omicron variant than with previous variants, according to healthcare providers. For this reason, the Louisiana Department of Health is no longer receiving allocations of these treatments from the federal government.

Louisiana has received a limited supply of another monoclonal antibody treatment, sotrovimab, which appears to remain effective against the Omicron variant for prevention of severe disease, according to the LDH.

Several hospitals in Louisiana, including Lake Charles Memorial Hospital, are expected to receive shipments of this new treatment.

The local health systems remind residents that vaccination is the best defense against severe COVID-19 infections and urge eligible individuals to consider getting a booster dose.

Copyright 2021 KPLC. All rights reserved.